about
Impact of comprehensive geriatric assessment on survival, function, and nutritional status in elderly patients with head and neck cancer: protocol for a multicentre randomised controlled trial (EGeSOR)Optimal management of elderly cancer patients: usefulness of the Comprehensive Geriatric Assessment.Optimizing the G8 Screening Tool for Older Patients With Cancer: Diagnostic Performance and Validation of a Six-Item Version.Assessment of solid cancer treatment feasibility in older patients: a prospective cohort study.Measurement of gait speed in older adults to identify complications associated with frailty: A systematic review.Early chemotherapy discontinuation and mortality in older patients with metastatic bladder cancer: The AGEVIM multicenter cohort study.Chronological Age and Risk of Chemotherapy Nonfeasibility: A Real-Life Cohort Study of 153 Stage II or III Colorectal Cancer Patients Given Adjuvant-modified FOLFOX6.Preferences about information and decision-making among older patients with and without cancer.Interrelations of immunological parameters, nutrition, and healthcare-associated infections: prospective study in elderly in-patients.Performance of Four Frailty Classifications in Older Patients With Cancer: Prospective Elderly Cancer Patients Cohort Study.Impact of comorbidities on hospital-acquired infections in a geriatric rehabilitation unit: prospective study of 252 patients.Prophylaxis of Venous Thromboembolism in Geriatric Settings: A Cluster-Randomized Multicomponent Interventional Trial.Interleukin-10 promoter (-1082) polymorphism in association with repeated hospital-acquired infections in elderly patients.[Oropharyngeal candidiasis in elderly patients]
P50
Q33844620-6CD98693-B636-4355-94C3-D57883CAFAF5Q34306560-EE54E50D-A0A0-4A9D-8723-8EDBBF2F7676Q36558425-2FE908A3-B364-42BF-883B-2539C39E69B8Q37644543-7A406163-10A9-4EBA-BC8A-74251D3F0DACQ38585242-4B65585C-2E5C-4FEB-A53C-322AE6A84D12Q39308532-7B6AD385-9D2E-4C74-BECE-20E1057B544BQ40337825-4A5DAA46-2BD9-43B4-BA34-03D74EC977A2Q40372637-F256C02E-BE26-4D49-A7E3-D6588E9668DCQ43978766-46D3BA41-5119-4B8E-B1BC-B0487E195480Q48710331-44B8B541-AB7C-44F2-B661-DD8345DCE5F1Q50920376-3BAE6F6D-F1F1-4DD3-9F1F-900B9DEA8A11Q51759292-8ADDD785-8D58-4C78-9F4E-6E36E52E6875Q54487975-8C754460-E2AC-47EA-A5EA-CD1D7A7196E7Q84131290-5E987B4D-96C9-46C1-9446-422EEED134B1
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Marie Laurent
@ast
Marie Laurent
@en
Marie Laurent
@es
Marie Laurent
@nl
type
label
Marie Laurent
@ast
Marie Laurent
@en
Marie Laurent
@es
Marie Laurent
@nl
prefLabel
Marie Laurent
@ast
Marie Laurent
@en
Marie Laurent
@es
Marie Laurent
@nl
P106
P31
P496
0000-0002-6484-1277